New eczema pill shows early promise in small trial
NCT ID NCT07336940
First seen Jan 14, 2026 · Last updated May 25, 2026 · Updated 16 times
Summary
This early-stage study tested a new drug called ENV-294 in 9 adults with moderate-to-severe atopic dermatitis (eczema). The main goal was to check if the drug is safe and tolerable when taken daily for 28 days. Researchers also looked for any changes in skin symptoms. This is a small, first-in-human trial, so results are preliminary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center for Dermatology Clinical Research, Inc.
Fremont, California, 94538, United States
-
J & S Studies
College Station, Texas, 77845, United States
-
Skin Sciences, PLLC
Louisville, Kentucky, 40217, United States
-
Texas Dermatology and Laser Specialists
San Antonio, Texas, 78218, United States
-
Virginia Dermatology & Skin Cancer Center
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.